Billiontoone Inc (BLLN)
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-11-04
$112.39-1.32%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-11-04
QuarterlyIQ Insights · BLLN
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | FY 2022 | |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenues | 436.9 | 305.1 | 152.6 | 71.7 | — |
| Cost of Revenues | 124.9 | 96.7 | 71.7 | 54.4 | — |
| Gross Profit | 312.0 | 208.5 | 80.9 | 17.3 | — |
| Operating Expenses & Income | |||||
| Selling, General & Admin | 200.8 | 143.1 | 91.5 | 64.4 | — |
| R&D Expenses | 66.5 | 49.4 | 36.6 | 22.4 | — |
| Operating Income | 44.7 | 16.0 | (47.1) | (69.5) | — |
| Earnings from Continuing Operations | |||||
| Interest Expense | — | 0.1 | — | — | — |
| Interest & Investment Income | 17.5 | 7.8 | 5.8 | 3.5 | — |
| Other Non-Operating Income / Expenses | 5.0 | (8.3) | 5.6 | (13.2) | — |
| EBT, Incl. Unusual Items | 49.7 | 7.8 | (41.5) | (82.7) | — |
| Income Tax Expense | 0.3 | 0.3 | 0.0 | 0.0 | — |
| Net Income | |||||
| Net Income | 49.4 | 7.5 | (41.6) | (82.7) | — |
| Per Share | |||||
| Basic EPS | 1.04 | 0.18 | (4.12) | (8.45) | — |
| Diluted EPS | 0.92 | 0.14 | (4.12) | (8.45) | — |
| Revenue per Share | 8.13 | — | — | — | — |
| Basic Weighted Avg Shares | 47.3 | 15.9 | 10.1 | 9.8 | — |
| Diluted Weighted Avg Shares | 53.7 | 21.2 | 10.1 | 9.8 | — |
| Supplemental | |||||
| EBITDA | — | 22.9 | (40.1) | (63.6) | — |
| EBIT | 44.7 | 16.0 | (47.1) | (69.5) | — |
| Effective Tax Rate | 0.7% | — | -0.1% | -0.0% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.